Skip to main content
. 2021 Oct 19;63(10):1323–1331. doi: 10.1177/02841851211041832

Table 6.

Patients with HCC experiencing PES* after TACE.

TACE treatment Post-TACE PES
TACE 1 56/87 (65)
TACE 2 43/68 (64)
TACE 3 29/57 (51)
TACE 4 18/40 (45)
TACE 5 12/25 (48)

Values are given as n (%).

*Defined as one or several of the following symptoms: pain; fever; nausea; and vomiting.

HCC, hepatocellular carcinoma; PES, post-embolization syndrome; TACE, transarterial chemoembolization.